⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL560211 | 0.92 | — | — | |
| SCHEMBL4656129 | 0.74 | — | — | |
| SCHEMBL8093995 | 0.73 | — | — | |
| SCHEMBL905422 | 0.73 | — | — | |
| SCHEMBL5871 | 0.63 | MEN1 (0.30) | — | |
| SCHEMBL8380251 | 0.63 | TSHR (0.30) | — | |
| SCHEMBL5469680 | 0.63 | — | — | |
| SCHEMBL4579560 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL8094540 | 0.61 | PARL (0.31) | — | |
| SCHEMBL131101 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3312 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-12496351-B2 | Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkers | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2025-12-16 | — | — | US | claimed |
| EP-4628492-A1 | PREPARATION METHOD FOR LINKER-DRUG CONJUGATE AND INTERMEDIATE THEREOF | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (CN) | 2025-10-08 | — | — | EP | claimed |
| EP-4601744-A1 | NEW COMPOUNDS, PROCESSES FOR PREPARING THE SAME AND THEIR USE AS DRUGS | B&A Oncomedical (FR) | 2025-08-20 | — | — | EP | claimed |
| US-12344625-B2 | Process for preparing rhenium chelated MAG3 oligonucleotides | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2025-07-01 | — | — | US | claimed |
| US-20250135028-A1 | TUNABLE POLYMERIC NANOPARTICLES FOR TARGETED AND SUSTAINED DELIVERY OF GLYCOPEPTIDE ANTIBIOTICS | INSMED INCORPORATED | 2025-05-01 | — | — | US | claimed |
| EP-4543990-A1 | INDOCYANINE GREEN (ICG) MODIFICATION FOR TREATMENT OF LIVER CANCER | The Children's Medical Center Corporation (US) | 2025-04-30 | — | — | EP | claimed |
| WO-2024140934-A1 | PREPARATION METHOD FOR LINKER-DRUG CONJUGATE AND INTERMEDIATE THEREOF | 上海复旦张江生物医药股份有限公司 | 2024-07-04 | — | — | WO | claimed |
| EP-4380962-A1 | PROCESS FOR THE PREPARATION OF SEMAGLUTIDE | MSN Laboratories Private Limited, R&D Center (IN) | 2024-06-12 | — | — | EP | claimed |
| WO-2024079128-A1 | NEW COMPOUNDS, PROCESSES FOR PREPARING THE SAME AND THEIR USE AS DRUGS | B&A ONCOMEDICAL (FR) | 2024-04-18 | — | — | WO | claimed |
| EP-0971945-A1 | URONIUM SALT CONJUGATE VACCINES | Lees, Andrew (US) | 2000-01-19 | — | — | EP | claimed |
| US-6015895-A | REACTING A LINKER COMPOUND WITH A HYDROXY GROUP OF A NUCLEOSIDE AND A SOLID SUPPORT CAPABLE OF ESTERIFICATION; LINKER IS STABILE AGAINST SPONTANEOUS HYDROLYSIS AND EASILY CLEAVED WHEN NECESSARY | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 2000-01-18 | — | — | US | claimed |
| EP-0877751-A1 | LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 1998-11-18 | — | — | EP | claimed |
| WO-1998042721-A1 | URONIUM SALT CONJUGATE VACCINES | LEES ANDREW (US) | 1998-10-01 | — | — | WO | claimed |
| US-5674531-A | CONTROLLED DRUG DELIVERY, BIODEGRADATION, NONAGGREGATING | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-10-07 | — | — | US | claimed |
| WO-1997023497-A1 | LINKER ARM FOR SOLID SUPPORT OLIGONUCLEOTIDE SYNTHESIS AND PROCESS FOR PRODUCTION THEREOF | UNIVERSITY TECHNOLOGIES INTERNATIONAL INC. (CA) | 1997-07-03 | — | — | WO | claimed |
| EP-0671169-A1 | Nanoparticles containing an active agent and a cetal-tartanic acid amides polymer, process for preparation thereof and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-09-13 | — | — | EP | claimed |
| EP-0565646-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1993-10-20 | — | — | EP | claimed |
| WO-1992018518-A1 | NUCLEOSIDES AND OLIGONUCLEOSIDES WITH A PHOSPHATE-FREE INTERNUCLEOSIDE BACKBONE AND PROCESS FOR PREPARING THE SAME | BAYLOR COLLEGE OF MEDICINE (US) | 1992-10-29 | — | — | WO | claimed |
| EP-0340605-A2 | Ruthenium complexes containing a DNA or RNA sequence | F. HOFFMANN-LA ROCHE AG (CH) | 1989-11-08 | — | — | EP | claimed |